Diabetes Mellitus, Type 2 Clinical Trials

185 recruiting

Diabetes Mellitus, Type 2 Trials at a Glance

186 actively recruiting trials for diabetes mellitus, type 2 are listed on ClinicalTrialsFinder across 6 cities in 59 countries. The largest study group is Not Applicable with 100 trials, with the heaviest enrollment activity in Seoul, Montreal, and Boston. Lead sponsors running diabetes mellitus, type 2 studies include Eli Lilly and Company, Stanford University, and University of Leicester.

Browse diabetes mellitus, type 2 trials by phase

Treatments under study

About Diabetes Mellitus, Type 2 Clinical Trials

Looking for clinical trials for Diabetes Mellitus, Type 2? There are currently 185 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes Mellitus, Type 2 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes Mellitus, Type 2 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 186 trials

Recruiting
Not Applicable

The eHealth Diabetes Remission Trial

Diabetes Mellitus, Type 2
Umeå University106 enrolled3 locationsNCT05491005
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Not Applicable

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Diabetes Mellitus, Type 2
Stanford University119,680 enrolled4 locationsNCT06251323
Recruiting

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Chronic Kidney DiseasesDiabetes Mellitus, Type 2Diabetic Nephropathy Type 2 - Uncontrolled
Medical College of Wisconsin330 enrolled1 locationNCT05692388
Recruiting
Not Applicable

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Diabetes MellitusDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Senseonics, Inc.80 enrolled1 locationNCT07386340
Recruiting
Not Applicable

ROME GS System Study

Diabetes Mellitus, Type 2DiabetesDiabetes Melletus, Type 1
Senseonics, Inc.60 enrolled4 locationsNCT07518004
Recruiting
Phase 2

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Diabetes Mellitus, Type 2
Eli Lilly and Company100 enrolled26 locationsNCT07215312
Recruiting
Phase 4

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company344 enrolled21 locationsNCT07438444
Recruiting
Phase 1

A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company40 enrolled1 locationNCT07299084
Recruiting
Phase 4

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Diabetes Mellitus, Type 2DiabetesType 2 Diabetes
Stanford University104 enrolled2 locationsNCT06657209
Recruiting
Not Applicable

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Diabetes Mellitus, Type 2
Cleerly, Inc.7,500 enrolled123 locationsNCT06112418
Recruiting

A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

Diabetes Mellitus, Type 2
Novo Nordisk A/S400 enrolled1 locationNCT07532863
Recruiting
Not Applicable

Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes

Diabetes Mellitus, Type 2
Massachusetts General Hospital280 enrolled1 locationNCT05420051
Recruiting
Phase 1Phase 2

A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus

ObesityDiabetes Mellitus, Type 2
Arrowhead Pharmaceuticals138 enrolled8 locationsNCT06937203
Recruiting
Phase 4

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Diabetes Mellitus, Type 2
Novo Nordisk A/S586 enrolled75 locationsNCT07112339
Recruiting
Not Applicable

Autologous SVF Therapy for Type 2 Diabetes

Diabetes Mellitus, Type 2
Kaiser Clinic and Hospital10 enrolled1 locationNCT07487467
Recruiting
Not Applicable

Project Dulce for Arab Americans With Type 2 Diabetes

Diabetes Mellitus, Type 2
Scripps Whittier Diabetes Institute48 enrolled2 locationsNCT05580536
Recruiting
Not Applicable

Food Insecurity Reduction & Strategy Team

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Food Insecurity
Stanford University160 enrolled1 locationNCT06329375
Recruiting
Not Applicable

Improving Health Outcomes With Kefir

Cardiovascular DiseasesDiabetes Mellitus, Type 2Systemic Inflammatory Response
University of Alberta156 enrolled1 locationNCT06695221
Recruiting

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Diabetes Mellitus, Type 2
University of Athens240 enrolled1 locationNCT03878706